|
FBXW11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.417500E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.235000E-03 |
| Normal-vs-Stage2 |
3.560000E-01 |
| Normal-vs-Stage3 |
3.575300E-03 |
| Normal-vs-Stage4 |
3.621400E-03 |
| Stage1-vs-Stage2 |
1.241780E-01 |
| Stage1-vs-Stage3 |
7.217200E-01 |
| Stage1-vs-Stage4 |
6.365200E-01 |
| Stage2-vs-Stage3 |
1.170020E-01 |
| Stage2-vs-Stage4 |
1.224250E-01 |
| Stage3-vs-Stage4 |
8.576200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.301800E-03 |
| Normal-vs-AfricanAmerican |
5.134600E-01 |
| Normal-vs-Asian |
5.596900E-03 |
| Caucasian-vs-AfricanAmerican |
1.607030E-01 |
| Caucasian-vs-Asian |
6.756200E-01 |
| AfricanAmerican-vs-Asian |
1.153770E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.037650E-03 |
| Normal-vs-Female |
8.535400E-03 |
| Male-vs-Female |
2.176600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.998500E-03 |
| Normal-vs-Age(41-60Yrs) |
5.099400E-03 |
| Normal-vs-Age(61-80Yrs) |
8.317500E-03 |
| Normal-vs-Age(81-100Yrs) |
1.187950E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.294600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.908800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.327400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.398200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.862400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.141200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.191000E-01 |
| Classical-VS-Follicular |
7.412000E-02 |
| Classical-VS-Other |
1.081570E-01 |
| Classical-VS-Normal |
3.077600E-02 |
| Tall-VS-Follicular |
9.724400E-01 |
| Tall-VS-Other |
3.056200E-01 |
| Tall-VS-Normal |
6.801300E-03 |
| Follicular-VS-Other |
3.728000E-01 |
| Follicular-VS-Normal |
3.081400E-03 |
| Other-VS-Normal |
1.198070E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.498830E-03 |
| Normal-vs-N1 |
7.396800E-04 |
| N0-vs-N1 |
2.174400E-01 |
|
|
